Medical staff in Western Australia have been warned after reports of the wrong immunisations being given to patients.

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

The Department of Health has sent an urgent reminder to medical staff to make sure they’re giving patients the right RSV ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

French drugmaker Sanofi SA (NASDAQ:SNY) on Monday said it is shipping Beyfortus (nirsevimab) starting in early Q3 to ensure broad availability well ahead of the 2025-2026 respiratory syncytial virus ...

Robert F. Kennedy Jr.’s vaccine advisory committee recommended Merck & Co.’s shot to prevent newborns from getting RSV, ...

Sanofi accelerates global shipping of Beyfortus to prepare healthcare providers months ahead of 2025-2026 RSV season Paris, June 9, 2025. Sanofi is shipping Beyfortus (nirsevimab) starting in ...

76% of patients in the Dupixent trial reached ≥75% improvement in eczema severity at 24 weeks. Sanofi has tripled Beyfortus production and doubled manufacturing sites since its 2023 launch. Get ...

Beyfortus, developed by the British-Swedish drugmaker AstraZeneca in partnership with the French pharmaceutical company Sanofi, was introduced in 2023 as game changing for infants since only one ...

Beyfortus, developed by the British-Swedish drugmaker AstraZeneca in partnership with the French pharmaceutical company Sanofi, was introduced in 2023 as game changing for infants since only one ...

Beyfortus, developed by the British-Swedish drugmaker AstraZeneca in partnership with the French pharmaceutical company Sanofi, was introduced in 2023 as game changing for infants since only one ...

Beyfortus, developed by the British-Swedish drugmaker AstraZeneca in partnership with the French pharmaceutical company Sanofi, was introduced in 2023 as game changing for infants since only one ...